Ellogon AI is a verified, high-potential MedTech startup (University of Amsterdam spin-off) developing CE-certified AI for cancer immunotherapy selection. While the project demonstrates high real-world utility and technical innovation (supported by €1M+ funding and pilot programs), the submission itself contained inaccurate and hallucinatory claims (e.g., 'most people have used my product', 'audience: everyone'). The score reflects the project's verified clinical potential and seed-stage traction, heavily penalized by the poor quality of the provided input data.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline